Stay updated on Tirzepatide in HFpEF & Obesity Clinical Trial
Sign up to get notified when there's something new on the Tirzepatide in HFpEF & Obesity Clinical Trial page.

Latest updates to the Tirzepatide in HFpEF & Obesity Clinical Trial page
- ChecktodayChange DetectedPublications section wording updated to say publications are automatically filled from PubMed and may or may not be about the study, with the revision label updated to v3.3.1. The previous wording indicating PubMed sources and the older revision label (v3.2.0) were removed.SummaryDifference0.8%

- Check8 days agoChange DetectedRemoved the government funding lapse notice that previously warned about potential delays and NIH operating status; no study content, enrollment data, or outcomes were changed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedThe update appears to be visual/UI changes only, with no alterations to the study description, eligibility criteria, endpoints, or locations.SummaryDifference0.2%

- Check50 days agoChange DetectedCore content updated with a government funding notice and updated operating-status guidance; version updated from v3.1.0 to v3.2.0.SummaryDifference2%

- Check58 days agoChange DetectedThe page now announces Revision: v3.1.0 and removes four drug-safety related topics, indicating content reorganization and scope narrowing.SummaryDifference0.2%

- Check72 days agoChange DetectedAdded the new Revision: v3.0.2, replacing v3.0.1. The Back to Top element has been removed.SummaryDifference0.1%

Stay in the know with updates to Tirzepatide in HFpEF & Obesity Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Tirzepatide in HFpEF & Obesity Clinical Trial page.